Introduction IBD patients are at risk of micronutrient deficiency including vitamin D. There is evidence that vitamin D deficiency is associated with poor disease activity.
Aims/Background To determine the vitamin D status and evaluate the effectiveness of oral vitamin D treatment in a sub-set of IBD patients at a University Hospital.
Method All IBD patients with serum vitamin D levels measured in 2011 were identified. Vitamin D deficiency was determined as plasma 25-hydroxyvitamin D levels <52 nmol/L. Oral vitamin D treatment was classified as ‘low dose’ when patients prescribed daily 800 units of vitamin D2/D3 and ‘high dose’ when given either 100'000 units once or 50'000 units weekly for 6 weeks. Treatment response was assessed within 6 months of treatment.
Results 205 IBD patients had their plasma vitamin D measured. 95 (46%) were found to be vitamin D deficient with no significant difference in the prevalence between Crohn's disease (CD) and ulcerative colitis (UC) patients (p=0.449). 32 treatment episodes had follow up measurement. Those who received ‘high dose’ regimen demonstrated a 150% increase in plasma vitamin D compared to a 34% increase in those put on ‘low dose’ regimen (p=0.001). There was no significant difference in treatment response between CD and UC patients (p=0.874) (table 1).
Conclusion Oral vitamin D replacement is an effective treatment for vitamin D deficiency in IBD patients and appears to be dose responsive, in both UC and CD patients. The optimal dose of oral vitamin D supplementation is yet to be determined, but higher doses are significantly more effective.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.